Artelo Biosciences (ARTL) announced the appointment of Mark Spring, CPA, as Chief Financial Officer, effective November 1, 2025. Spring had been serving as a financial consultant to the Company since December 2024.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARTL:
- Artelo Biosciences Enters Cooperation Agreement with Farb
- Artelo announces expanded clinical data to be presented on ART26.12, ART27.13
- Artelo prices 441,210 shares at $4.40 in underwritten public offering
- Artelo Biosciences files to sell common stock, no amount given
- Artelo Biosciences presents interim Phase 2 CAReS data on ART27.13